What were the main drivers of Colgate-Palmolive's net sales performance in 2014?

In 2014, Colgate-Palmolive's worldwide net sales decreased by 1.0%. However, organic sales, which exclude foreign exchange impacts, acquisitions, and divestitures, grew by a strong 5.0%. This growth was primarily driven by volume increases and net selling price improvements, particularly in the Oral Care, Personal Care, and Home Care categories, with specific strength noted in toothpaste, manual toothbrushes, bar soap, and fabric softeners. The Pet Nutrition segment also contributed positively with a 4.0% organic sales increase driven by its Prescription Diet category.

What are the significant risks and challenges facing Colgate-Palmolive, as outlined in the filing?

The company faces several significant risks, including: 1) Exposure to foreign currency fluctuations and economic/political instability in its extensive international operations (approximately 80% of net sales are outside the U.S.), with Venezuela being a notable example of challenging conditions. 2) Intense competition from global and local competitors, potentially impacting pricing, promotional activities, and new product introductions. 3) Legal and regulatory risks, including ongoing investigations by competition authorities in Europe and potential issues related to product ingredients like Triclosan. 4) Volatility in raw material and energy costs. 5) Dependence on key retailers and evolving sales channels, such as e-commerce. 6) Risks associated with product innovation and intellectual property protection.

How is Colgate-Palmolive managing costs and improving efficiency?

Colgate-Palmolive is actively managing costs through its "funding-the-growth" initiatives, which focus on reducing expenses related to direct materials, indirect expenses, and distribution and logistics. Additionally, the company is executing a "2012 Restructuring Program," which aims to enhance efficiency and profitability through initiatives like expanding commercial hubs, extending shared business services, and optimizing the global supply chain and facilities. This program is estimated to generate annual pre-tax savings of $405-$475 million once fully implemented.

What is the company's strategy for returning capital to shareholders?

Colgate-Palmolive remains committed to returning capital to shareholders through dividends and share repurchases. In 2014, dividend payments increased to $1,446 million, with the quarterly common stock cash dividend being raised to $0.36 per share. The company also repurchased a significant number of shares. Following the reporting period, on February 19, 2015, the Board authorized a new $5 billion share repurchase program, replacing the previous one, indicating a continued focus on capital allocation to shareholders.

CL 10-K FY2014 Annual Report — Revenue, Net Income, EPS

Summary

Colgate-Palmolive Company's 2014 Form 10-K report highlights a year of challenges and strategic initiatives. While the company experienced a slight decrease in overall net sales (-1.0%) primarily due to adverse foreign exchange impacts (-6.0%), it achieved a solid 5.0% organic sales growth, driven by strong performance in Oral Care and Pet Nutrition segments. The company continued to invest in its core brands and innovation, while also managing costs through its "funding-the-growth" initiatives and a significant "2012 Restructuring Program" aimed at enhancing efficiency and profitability. Significant risks were noted, particularly related to the company's extensive international operations, including currency fluctuations and economic instability in markets like Venezuela. Legal and regulatory matters, including ongoing competition investigations in Europe, also posed challenges. Despite these headwinds, Colgate-Palmolive maintained its market leadership in key categories and demonstrated a commitment to returning value to shareholders through dividends and share repurchases. The company's outlook for the coming year acknowledged continued global macroeconomic challenges but expressed confidence in its strategic focus and financial strength to drive long-term shareholder value.

Financial Highlights

55 data points

Beta

Revenue

$17.28B

0.6% Gross Margin

Net Income

$2.18B

0.1% Net Margin

EPS (Diluted)

$2.36

Total Assets

$13.44B

Cash & Equivalents

$1.09B

Free Cash Flow

$2.54B

Financial Statements

Beta

Revenue	$17.28B
Cost of Revenue	$7.17B
Gross Profit	$10.11B
R&D Expenses	$277.00M
SG&A Expenses	$5.98B
Operating Income	$3.56B
Interest Expense	$134.00M
Net Income	$2.18B
EPS (Basic)	$2.38
EPS (Diluted)	$2.36
Shares Outstanding (Basic)	915.10M
Shares Outstanding (Diluted)	924.30M

Key Highlights

1Despite a 1.0% decrease in reported net sales in 2014, Colgate-Palmolive achieved a robust 5.0% organic sales growth, demonstrating underlying business strength.
2The "2012 Restructuring Program" continued, with expanded initiatives focused on commercial hubs, shared services, and supply chain optimization, aiming for annual pre-tax savings of $405-$475 million.
3Significant foreign currency headwinds impacted reported results, with a negative foreign exchange impact of 6.0% on worldwide net sales.
4Operating profit remained stable at $3,557 million, with a non-GAAP operating profit margin improvement of 60 basis points due to efficient cost management and reduced SG&A expenses.
5The company highlighted challenges in Venezuela, including currency devaluations and price controls, which resulted in $327 million in pre-tax losses from remeasurement charges in 2014.
6Colgate-Palmolive continued its capital return strategy, with dividends paid increasing to $1,446 million and a new $5 billion share repurchase program authorized.
7Market leadership was maintained in key categories, with global toothpaste market share at 44.4% and manual toothbrush market share at 33.4% for full-year 2014.

COLGATE PALMOLIVE CO Annual Report, Year Ended Dec 31, 2014

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions